Sphingomyelinase and phospholipase A2 regulate type I deiodinase expression in FRTL-5 cells

Thyroid

Volumn 7, Issue 4, 1997, Pages 647-654

  Pekary, A Eugene ^a,b   Chopra, Inder J ^a   Berg, Loretta ^a   Hershman, Jerome M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CERAMIDE; PHOSPHOLIPASE A2; SPHINGOMYELIN PHOSPHODIESTERASE; THYROXINE DEIODINASE; GAMMA INTERFERON; INTERLEUKIN 1; IODIDE PEROXIDASE; MESSENGER RNA; PHOSPHOLIPASE A; THYROTROPIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME REGULATION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SECOND MESSENGER; THYROID HORMONE METABOLISM; ANIMAL; CELL LINE; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; KINETICS; METABOLISM; RAT; THYROID GLAND;

ANIMALS; ARACHIDONIC ACID; CELL LINE; CERAMIDES; CULTURE MEDIA; ENZYME ACTIVATION; GENE EXPRESSION; INTERFERON TYPE II; INTERLEUKIN-1; IODIDE PEROXIDASE; KINETICS; PHOSPHOLIPASES A; RATS; RNA, MESSENGER; SPHINGOMYELIN PHOSPHODIESTERASE; THYROID GLAND; THYROTROPIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030612099     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.647     Document Type: Article

References (35)

1. Beutler B 1992 Tumor Necrosis Factors. Raven Press, New York.
2. Roberts AB, Sporn MB (eds) 1991 Peptide Growth Factors and Their Receptors, Vols. I and II. Springer-Verlag, New York.
3. Pang X-P, Yoshimura M, Hershman JM 1993 Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-α. Thyroid 3:325-330.
4. 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, and interferon-γ in human thyrocytes in suspension culture. J Clin Endocrinol Metab 70:1735-1743.
5. Warzocha K, Bienvenu J, Coiffier B, Salles G 1995 Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor mechanism. Eur Cytokine Netw 6:83-96.
6. Jayadev S, Linardic CM, Hannun YA 1994 Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem 269:5757-5763.
7. Kolesnick RN 1991 Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30:1-38.
8. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K 1995 PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961-1969.
9. Pekary AE, Berg L, Santini F, Chopra I, Hershman JM 1994 Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 101:R31-R35.
10. Tang K-T, Braverman LE, DeVito WJ 1995 Tumor necrosis factor-α and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology 136:881-888.
11. Hashimoto H, Igarashi N, Miyawaki T, Sato T. 1995 Effect of tumor necrosis factor-α, interIeukin-1β, and interleukin-6 on type I iodothyronine 5′-deiodination in rat thyroid cell line, FRTL-5. J Interferon Cytokine Res 15:367-375.
12. Berry MJ, Bau L, Larsen PR 1991 Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349:438-440.
13. Sporn MB, Roberts AB 1992 Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119: 1017-1021.
14. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011.
15. Chanoine J-P, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S, Leonard JL 1993 The thyroid gland is a major source of circulating T3 in the rat. J Clin Invest 91:2709-2713.
16. Toyoda N, Nishikawa M, Mori Y, Gondou A, Ogawa Y, Yonemoto T, Yoshimura M, Masaki H, Inada M 1992 Thyrotropin and triiodothyronine regulate iodothyronine 5′-deiodinase messenger ribonucleic acid levels in FRTL-5 rat thyroid cells. Endocrinology 131:389-394.
17. Visser TJ 1988 In: Cooke BA, King RJB, van der Molen JJ (eds) Hormones and Their Actions, Part I. Elsevier, Amsterdam, p. 81.
18. Salvatore D, Tu H, Harney JW, Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968.
19. Croteau W, Davey JC, Gallon VA, St. Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase: A selenoprotein differentially expressed and regulated in the human brain and other tissues. J Clin Invest 98:405-417.
20. Salvatore D, Tibor B, Harney JW, Larsen PR 1996 Molecular biology and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308-3315.
21. Pang X-P, Hershman JM, Mirell CJ, Pekary AE. 1989 Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor α (cachectin). Endocrinology 125:76-84.
22. Pang X-P, Hershman JM, Chung M, Pekary AE 1989 Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulatin of the receptors by thyrotropin. Endocrinology 125:1783-1788.
23. Pang X-P, Hershman JM, Smith V, Pekary AE, Sugawara M 1990 The mechanism of action of tumour necrosis factor-α and interleukin 1 on FRTL-5 rat thyroid cells. Acta Endocrinol 123:203-210.
24. Ji L, Zhang G, Uematsu S, Akahori Y, Hirabayashi Y 1995 Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 358:211-214.
25. Pardridge WM, Fierer G 1990 Transport of tryptophan into brain from the circulating, albumin-bound pool in rats and in rabbits. J Neurochem 54:971-976.
26. Wolfe LS, Horrocks LA 1994 Eicosanoids. In: Siegel GJ, Agranoff W, Albers RW, Molinoff PB (eds) Basic Neurochemistry. Fifth Edition, Raven Press, New York, p 475-490.
27. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
28. Ausubel FM, et al. 1996 Current Protocols in Molecular Biology. Greene Publishing Associates and Wiley Interscience, New York, p 4.9.1.
29. Santini F, Chopra I 1992 A radioimmunoassay of rat type I iodothyronine 5′-monodeiodinase. Endocrinology 131:8 63-870.
30. Chen G, Pekary AE, Hershman JM 1992 Aging of FRTL-5 rat thyroid cells causes sensitivity to cytotoxicity induced by tumor necrosis factor-α. Endocrinology 131:863-870.
31. Heller RA, Kronke M 1994 Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9.
32. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF 1985 Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 60:666-672.
33. Abe A, Radin NS, Shayman JA 1996 Induction of glucosylceramide synthase by synthase inhibitors and ceramide. Biochim Biophys Acta 1299:333-341.
34. Ji L, Zhang G, Hirabayashi Y 1995 Tumor necrosis factor alpha increases tyrosine phosphorylation of a 23-kDa nuclear protein in U937 cells through ceramide signaling pathway. Biochem Biophys Res Commun 215:489-496.
35. Bornstein P 1992 Thrombospondins: Structure and regulation of expression. FASEB J 6:3290-3299.